![]() |
||||||
|
||||||
The epidemiology of breast cancer in Maori women in Aotearoa
New Zealand: implications for ethnicity data analysis
Elana Curtis, Craig Wright, Madeleine Wall
The epidemiology of breast cancer in New Zealand women has
been well described from a total population perspective, but Maori specific
analyses have produced inconsistent results.1–8
This paper presents the methods used to analyse breast cancer incidence
and mortality in Maori and non-Maori women for a 5-year period
(1996–2000). A full discussion of the ethnic disparities identified by
this analysis is presented in an accompanying
paper.9
BackgroundBreast cancer is a major cause of
death for women both internationally and in New
Zealand.2,10 Ethnic disparities in breast
cancer mortality have been consistently documented with Maori women having a
higher mortality rate than non-Maori.2,11,12 In
contrast, ethnic differences in breast cancer incidence rates between Maori and
non-Maori are less consistent with conflicting estimates stating Maori risk as
similar, higher and/or lower than
non-Maori.2–5,7 Explanations for these
findings may include: variations in the analytical frameworks used to explore
ethnic differences, such as sole versus total ethnic group analyses (the latter
includes people who identify with only one ethnic group plus those people who
identify with more than one ethnic group, where ethnicity is assigned by
application of a prioritisation rule—i.e. Maori first, then Pacific
Island, European and Other)2,4,7; blood quantum
versus cultural affiliation definitions of
ethnicity,4 and a lack of equal explanatory
power—i.e. small sample sizes for Maori compared to
non-Maori.3,5
In addition, there are problems with ethnicity data within
cancer registration and death records in New Zealand. Cancer registration data
come primarily from laboratory information or hospital records. Although
ethnicity is supposed to be self-defined in these records, reviews have shown
that this is not always the case, particularly in the hospital
setting.13 Furthermore, although it has been
possible to record multiple ethnic groups since July 1996, less than 2% of
hospital records had ethnicity recorded as including more than one ethnic group
during 1997–1998, suggesting that this option was either not given or not
recorded by hospital staff.14 Approximately 10%
of breast cancer registrations in 1999 had ethnicity recorded as ‘not
stated’.15
There are similar issues with cancer mortality data. Prior
to September 1995, deaths were officially registered as Maori, usually by
funeral directors, if the deceased was determined to be of half or more Maori
ancestry based on the descent of their
parents.13 This led to an under-reporting of
Maori deaths prior to 1995.16,17 Since 1995,
the classification of ethnicity on death records has changed to determine the
ethnicity (rather than ancestry) of all deceased with multiple options available
as in the census.13 Although this has led to an
increased recording of Maori in mortality datasets, there is still evidence of
undercounting.12,13
This paper recognises the need to review the quality of
ethnicity data within cancer registration and mortality datasets when
considering Maori vs non-Maori disparities in breast cancer incidence and
mortality. This is consistent with the recently released
New Zealand Cancer Control Strategy,
which aims to reduce both the incidence and impact of cancer and inequalities
with respect to cancer.18
MethodologyThis paper uses the
methodological approach of Kaupapa Maori Research
(KMR)19. To date, KMR has been used primarily
within a qualitative setting. However, a number of more recent studies have
described the use of KMR within quantitative analyses, particularly within
health.20-22 This paper reflects a KMR approach
because: it puts Maori at the centre of enquiry (i.e. focuses on Maori data and
identifies the best quality information available); performs a Maori vs
non-Maori analysis (i.e. ensures that Maori are not treated simply as a subgroup
of the total population); maximises the quality of ethnicity data (i.e. uses
multiple methods to assign ethnicity), and maximises statistical power (i.e. by
aggregating five years of data).
This approach reflects the principle of ‘equal
explanatory power’, which promotes the need to gather data to the same
breadth and depth for the Maori population as it is collected for the non-Maori
population in order to appropriately analyse Maori vs non-Maori
inequalities.23
MethodsNumerator dataNumerator
data on breast cancer incidence and mortality were obtained from national cancer
registration information (ICD9-CM code 174 Female
Breast)15 and mortality information
(ICD-9-CMA-II code 174 Malignant neoplasm of the female
breast).24 To assess the extent of the Maori
undercount associated with routinely collected datasets, four different methods
were used to calculate breast cancer incidence and mortality. These methods were
chosen because they reflect current practice in New Zealand, and they allow
recently developed analyses (i.e. New Zealand Census Mortality Study [NZCMS] and
ever-Maori adjustments) to be examined and compared with unadjusted
datasets.
NZCMS
mortality-adjusted estimates—These estimates draw on adjustors from
the NZCMS, which is a record linkage study in which death registration data are
anonymously and probabilistically linked to census
data.25 Ethnic specific rates are calculated by
multiplying the Census Mortality adjustor with either the incidence or mortality
rate for each age group. As this corrects the estimate for numerator-denominator
bias, the NZCMS adjustment is used as the ‘gold standard’ against
which other methods are compared in this
paper.12 It is uncertain how valid it is to
apply this method to morbidity data, such as cancer registrations, because
ethnicity information in morbidity data has not yet been matched to census
ethnicity information. An assumption has been made that the problems with
ethnicity data collection are similar between routinely collected data sets.
Thus, applying a mortality adjustor to morbidity data is likely to produce more
accurate estimates, and this approach is consistent with recent Ministry of
Health cancer analyses.2
Ever Maori-adjusted
estimates—Ethnicity is adjusted according to whether or not any
previous admission for patients (as identified by their unique NHI identifiers)
had been recorded as Maori, either sole or total, in any admission record at any
time or on the death certificate. All remaining records, including those with no
ethnicity specified in the NHI unique identifier, were classified as non-Maori.
Other researchers have used this method to reduce the undercount of Maori in
routinely collected datasets.20,21 We
hypothesised that the ever-Maori approach would approximate the NZCMS
adjustment, but probably corrects Maori rates for older age groups better than
for younger age groups. This reflects the fact that older people are more likely
than younger people to have had previous hospital admissions, and are therefore
more likely to have an NHI unique identifier by which to assign an ever-Maori
ethnicity classification.
National Health Index
(NHI)-adjusted estimates—Ethnicity is adjusted according to the
most recent NHI ethnicity recorded in hospital admission data. We expected that
this estimate would under-estimate total Maori and over-estimate sole Maori
rates compared with NZCMS-adjusted rates. This effect may be even greater than
that seen in the unadjusted source information because NHI data only record
ethnicity on the most recent publicly-funded hospital admission.
Unadjusted source
information—Ethnicity is identified according to the classification
recorded at either the cancer or death registration event. This estimate depends
on the quality of data in routinely collected cancer registration and mortality
datasets. The New Zealand Census Mortality Study indicates that this approach is
likely to under-estimate total Maori and over-estimate sole Maori
rates.12
Denominator dataDenominator
data were mean resident population estimates at the year ended 30 June, sourced
from Statistics New Zealand estimates based on results from the 1996 and 2001
Censuses of Population and Dwellings.15,24,26
Denominator ethnicity was identified as non-Maori and
either:
Data AnalysisAll statistical analyses were
conducted using the SAS system for Windows version 8.2. As this study utilised
data collected from cancer registry and mortality records, it was assumed that
all cancers and cancer deaths in New Zealand had been obtained. Therefore, the
confidence limits provided reflect the uncertainty due to misassignment of
ethnicity to each cancer incidence or death event. A Delete-A-Group Jacknife
method was used to estimate the confidence intervals around the risk
ratios.27 This
involves randomly allocating each individual in the female population to one of
one hundred groups. The risk ratios are then recalculated one hundred times
after deleting only those women assigned to each group. The variation in the
distribution of Delete-A-Group Jacknife estimates were used as a measure of the
error in the risk ratios due to misassignment of ethnicity, and the resulting
confidence intervals were then
log-transformed.28
ResultsIncidenceTable 1
presents the total number of breast cancer registrations in New Zealand for the
years 1996–2000 by total and sole ethnicity. A total of 10,524 records
were analysed for unadjusted, NHI-adjusted, and ever Maori-adjusted estimates;
10,424 for NZCMS-adjusted total; and 10,680 for NZCMS-adjusted sole. The
difference in total numbers reflects the fact that NZCMS adjustors have been
smoothed to allow 5-year age group adjustors. While the total numbers are not
exactly the same, the relative proportions are correct based on the smoothing
function used.26 The percentage of total Maori
women ranged from 6.2% (NHI) to 8.6% (ever-Maori). Sole Maori percentages were
slightly lower with findings ranging from 5.7%(NHI) to
7.5%(unadjusted).
Table 2 presents age-specific relative risk (Maori vs
non-Maori) of breast cancer incidence for unadjusted, NHI, ever-Maori and
NZCMS-adjusted estimates. Overall, the relative risk of breast cancer incidence
is generally higher for sole Maori ethnicity compared with total Maori ethnicity
analyses. With respect to total findings, the NHI-adjusted estimate varies most
from the NZCMS-adjusted estimate. Both the unadjusted and ever-Maori estimates
appear to be relatively similar to the NZCMS-adjusted estimate. When comparing
sole Maori findings, the unadjusted estimate is the least consistent with the
NZCMS-adjusted one, over-estimating sole Maori risk of developing breast cancer.
The NHI-adjusted sole Maori estimate is comparable with the NZCMS-adjusted
estimate overall; however, it also appears to overestimate Maori breast cancer
incidence at younger ages (i.e. 15–29 years).
MortalityTable 3 presents total female breast
cancer deaths by total and sole ethnicity in New Zealand during the years
1996-2000. A total of 2577 deaths were analysed for unadjusted, NHI-adjusted and
ever Maori-adjusted estimates and 2560 deaths for NZCMS-adjusted. The proportion
of total Maori women ranged from 7.3% to 9.9%. Sole Maori proportions were
similar with estimates ranging from 7.1%(NHI) to 9.9% (NZCMS).
Table 4 presents age-specific relative risk (Maori vs
non-Maori) of breast cancer mortality for the unadjusted, NHI, ever-Maori, and
NZCMS-adjusted estimates. Similar to breast cancer incidence findings, the
relative risk estimates for mortality are greater for sole Maori than for total
Maori ethnicity.
With respect to total Maori mortality findings, the
NHI-adjusted results are least consistent with the NZCMS-adjusted estimates.
This is followed by unadjusted and ever-Maori estimates that both have a similar
risk pattern to the NZCMS-adjusted estimates.
With respect to sole Maori mortality findings, the
unadjusted results are least consistent with the NZCMS-adjusted estimate,
overestimating the sole Maori risk of death when compared with the
NZCMS-adjusted estimate. Although the NHI sole estimate still differs from the
NZCMS ‘gold standard’ one, this difference is less than the
unadjusted sole Maori estimate. This is to be expected because data obtained
from the National Health Index underestimate the number of Maori. Therefore (in
the case of sole Maori estimates) NHI adjustment reduces the overestimation of
sole Maori numbers found in unadjusted estimates. This results in sole Maori NHI
findings being more closely aligned to the NZCMS ‘gold standard’
than unadjusted sole Maori findings (the opposite to what was found for total
Maori results).
Figures 1 and 2 present the age-specific relative risk of
total Maori and sole Maori breast cancer incidence and mortality for each
estimate. As noted previously, NHI-adjusted and unadjusted estimates are least
similar to NZCMS-adjusted estimate, with ever Maori-adjusted risk estimates
closely approximating NZCMS-adjusted estimates for both incidence and mortality
data.
Overall, the majority of confidence intervals across the
seven incidence estimates include one, and therefore the age-specific relative
risks are not significantly different at the 95 % level of confidence. The risk
ratios for the under-30 age groups should be interpreted cautiously given the
low incidence rates in these age groups. In contrast to breast cancer incidence
findings, confidence intervals for Maori vs non-Maori mortality relative risks
in women aged 25-59 years did not include one and therefore are statistically
significant at the 95% level of confidence
DiscussionThis study found different breast
cancer incidence and mortality rates when different methods were used to
estimate Maori and non-Maori ethnicity. These results confirm previous findings
of the unreliable quality of ethnicity data in routinely collected datasets.
With respect to total findings for mortality, the
NHI-adjusted and unadjusted estimates were least similar to NZCMS-adjusted
estimates. These findings were predicted and are consistent with other
analyses.12 However, it is concerning that
ethnicity data obtained from mortality datasets after 1995 continue to
undercount Maori despite attempts to align ethnicity collection with that of the
census during this period. This highlights the ongoing presence of
numerator/denominator bias and reinforces the need to assume an undercount of
Maori in mortality datasets. Accordingly, the method used in this paper to
reassign ethnicity using NZCMS derived adjustors should be considered routinely.
Of note, the ever-Maori estimate closely approximates the NZCMS-adjusted
estimate representing an alternative option for adjustment.
Consistent with other ethnic analyses, this study found that
the mortality risk was higher for women who identified solely as Maori compared
with women who identified themselves as belonging to more than one ethnic
group.29 One proposed explanation for this
finding is that people identified as Maori (assumed to be more likely for the
sole Maori ethnic group) are at increased risk of institutional racism and
differential health care access, and therefore differential health
outcomes.29 This hypothesis supports the
ongoing examination of breast cancer incidence and mortality rates by both sole
and total Maori ethnicity.
Concerns about the validity of applying the NZCMS adjustor
to cancer registration data remain. While this analysis supports the application
of mortality adjustors to morbidity data, the findings are suggestive rather
than conclusive. In particular, we cannot conclude whether the use of NZCMS or
ever Maori-adjusted morbidity data is appropriate in other contexts—e.g.
data collected prior to 1996, fewer years of data, or data reviewing rarer
diseases or health outcomes with lower incidence.
The relatively short study period and modest number of
breast cancer events may affect the pattern observed between the different
estimates, and a similar analysis on a larger dataset would be worthwhile.
Ideally, cancer registration data should be linked with census information to
quantify the ethnicity misclassification as in the New Zealand Census Mortality
Study. This analysis is currently underway at the Wellington School of Medicine
(personal communication, Dr Martin Tobias, 2004) and will aid future ethnic
analyses of breast cancer incidence.
Despite these limitations, this study represents the first
time an analysis of cause-specific incidence and mortality has been performed in
New Zealand using and comparing multiple methods of ethnicity adjustment. In
addition, these estimates are the best available for age-specific Maori rates of
breast cancer incidence and mortality, and they represent a significant advance
in the quality of ethnicity data on which to base breast cancer screening policy
and treatment interventions. The use of a Kaupapa Maori Research approach within
a quantitative setting has provided new information that will guide the approach
to future analyses of breast cancer data in Maori and non-Maori women.
In conclusion, NZCMS or ever Maori-adjusted breast cancer
incidence and mortality estimates are the measures of choice for analysing Maori
data. If unadjusted or NHI data have to be used, then the undercount of Maori in
the data should be acknowledged. This paper reinforces the need to improve the
collection and analysis of both sole and total ethnicity data in New
Zealand so that Maori vs non-Maori disparities
in breast cancer can be appropriately identified, monitored, and eventually
eliminated.
Author
information: Elana T Curtis (Te
Arawa); Public Health Medicine Specialist, Harkness Fellow in Health Care
Policy, Division of General Internal Medicine, University of California San
Francisco, San Francisco, USA; Craig Wright, Statistics Advisor, Public Health
Intelligence, Ministry of Health, Wellington; Madeleine Wall
(Te Rarawa/Te Aupouri), Clinical Leader
of BreastScreen Aotearoa, National Screening Unit, Ministry of Health,
Wellington
Acknowledgments: We
acknowledge the support received from the National Screening Unit, Public Health
Intelligence, and Te Ropu Rangahau Hauora a Eru Pomare. In particular, we thank
Dr Ashley Bloomfield and Ms Bridget Robson for their assistance in the study
design and analysis, and for helpful comments on earlier drafts of this paper.
In addition, we acknowledge Dr Papaarangi Reid, Ms Donna Cormack, and Dr Martin
Tobias for their contribution to this manuscript. Dr Curtis is also grateful for
support received from the John McCleod Fellowship (Australasian Faculty Public
Health Medicine) that facilitated her to work on this manuscript.
(The authors were employees of the New Zealand Ministry
of Health at the time this paper was written. The views expressed in this paper
are the authors’ own and do not represent the views or policies of the
Ministry of Health. The paper was submitted for publication with the permission
of the Director General of Health.)
Correspondence: Dr
Madeleine Wall, National Screening Unit, Ministry of Health, PO Box 5013,
Wellington. Fax: (04) 495 4484; email: madeleine_wall@moh.govt.nz
References:
|
||||||
| Current
issue | Search journal |
Archived issues | Classifieds
| Hotline (free ads) Subscribe | Contribute | Advertise | Contact Us | Copyright | Other Journals |